Faculty Opinions recommendation of The X-ray crystal structure and putative ligand-derived peptide binding properties of gamma-aminobutyric acid receptor type A receptor-associated protein.

Author(s):  
Stanley Froehner
2001 ◽  
Vol 277 (7) ◽  
pp. 5556-5561 ◽  
Author(s):  
David Knight ◽  
Richard Harris ◽  
Mark S. B. McAlister ◽  
John P. Phelan ◽  
Stella Geddes ◽  
...  

2017 ◽  
Vol 815 ◽  
pp. 49-55 ◽  
Author(s):  
Hedwig Irl ◽  
Stephan Kratzer ◽  
Stefan Schwerin ◽  
Eberhard Kochs ◽  
Manfred Blobner ◽  
...  

2020 ◽  
Vol 33 (3) ◽  
pp. 372-380
Author(s):  
Chu-Yueh Guo ◽  
Jeffrey M. Gelfand ◽  
Michael D. Geschwind

2016 ◽  
Vol 291 (23) ◽  
pp. 12394-12407 ◽  
Author(s):  
Yasuko Nakamura ◽  
Danielle H. Morrow ◽  
Amit Modgil ◽  
Deborah Huyghe ◽  
Tarek Z. Deeb ◽  
...  

2014 ◽  
Vol 120 (3) ◽  
pp. 639-649 ◽  
Author(s):  
Stephan Kratzer ◽  
Hedwig Irl ◽  
Corinna Mattusch ◽  
Martina Bürge ◽  
Jörg Kurz ◽  
...  

Abstract Background: Tranexamic acid (TXA) is commonly used to reduce blood loss in cardiac surgery and in trauma patients. High-dose application of TXA is associated with an increased risk of postoperative seizures. The neuronal mechanisms underlying this proconvulsant action of TXA are not fully understood. In this study, the authors investigated the effects of TXA on neuronal excitability and synaptic transmission in the basolateral amygdala. Methods: Patch clamp recordings and voltage-sensitive dye imaging were performed in acute murine brain slices. Currents through N-methyl-d-aspartate, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and γ-aminobutyric acid receptor type A (GABAA) receptors were recorded. GABAA receptor–mediated currents were evoked upon electrical stimulation or upon photolysis of caged GABA. TXA was applied at different concentrations. Results: Voltage-sensitive dye imaging demonstrates that TXA (1 mM) reversibly enhances propagation of neuronal excitation (mean ± SEM, 129 ± 6% of control; n = 5). TXA at concentrations of 0.1, 0.3, 1, 5, or 10 mM led to a dose-dependent reduction of GABAA receptor–mediated currents in patch clamp recordings. There was no difference in the half-maximal inhibitory concentration for electrically (0.76 mM) and photolytically (0.84 mM) evoked currents (n = 5 to 9 for each concentration), and TXA did not affect the paired-pulse ratio of GABAA receptor–mediated currents. TXA did not impact glutamatergic synaptic transmission. Conclusions: This study clearly demonstrates that TXA enhances neuronal excitation by antagonizing inhibitory GABAergic neurotransmission. The results provide evidence that this effect is mediated via postsynaptic mechanisms. Because GABAA receptor antagonists are known to promote epileptiform activity, this effect might explain the proconvulsant action of TXA.


1994 ◽  
Vol 91 (7) ◽  
pp. 2815-2818 ◽  
Author(s):  
C. T. Culiat ◽  
L. J. Stubbs ◽  
C. S. Montgomery ◽  
L. B. Russell ◽  
E. M. Rinchik

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Tania Ahuja ◽  
Ofole Mgbako ◽  
Caroline Katzman ◽  
Allison Grossman

This case report describes the development of withdrawal from phenibut, a gamma-aminobutyric acid-receptor type B agonist. Although phenibut is not an FDA-approved medication, it is available through online retailers as a nootropic supplement. There are reports of dependence in patients that misuse phenibut. We report a case in which a patient experienced withdrawal symptoms from phenibut and was successfully treated with a baclofen taper. This case report highlights the development of phenibut use disorder with coingestion of alcohol and potential management for phenibut withdrawal. We believe clinicians must be aware of how phenibut dependence may present and how to manage the withdrawal syndrome.


Sign in / Sign up

Export Citation Format

Share Document